NCT02698085

Brief Summary

Diacutaneous Fibrolysis is a manual method of treatment, addressed to mechanical pain of the neuromusculoskeletal system. In the clinical practice a favorable effect is observed in patients with carpal tunnel syndrome, but there is no published studies evaluating the results os this technique. The objective of this trial is to evaluate if Diacutaneous Fibrolysis is more effective in symptoms, function, grip, mechanosensitivity and neural conduction velocity compared to a placebo. For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of carpal tunnel syndrome (low to moderate intensity) with a neurophysiological test. Patients included are randomized into 2 groups one receive Diacutaneous Fibrolysis and the other placebo. Both groups receive 5 treatment sessions. The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session. Patients who participated in placebo group, when the intervention finish the investigators will be given the opportunity to receive the actual technique

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2016

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 3, 2016

Completed
29 days until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2016

Completed
Last Updated

November 21, 2017

Status Verified

November 1, 2017

Enrollment Period

5 months

First QC Date

February 3, 2016

Last Update Submit

November 19, 2017

Conditions

Keywords

carpal tunnel syndromephysiotherapymanual therapy

Outcome Measures

Primary Outcomes (3)

  • Intensity symptoms pre-intervention with a visual analogic scale

    The investigators measure the intensity of symptoms with a visual analogic scale at baseline.

    pre-intervention

  • Intensity symptoms post-intervention with a visual analogic scale

    The investigators measure the intensity of symptoms with a visual analogic scale at the end of the intervention (2 weeks after pre-intervention) the investigators measured the intensity of symptoms (through study completion, an average 15 days)

    post-intervention

  • Intensity symptoms after month with a visual analogic scale

    The investigators measure the intensity of symptoms with a visual analogic scale after month of post-intervention.

    after month

Secondary Outcomes (7)

  • Upper limb function pre-intervention with a validated questionnaire (DASH)

    pre-intervention

  • Mechanosensitivity of median nerve pre-intervention with neurodynamic test

    Pre-intervention

  • Mechanosensitivity of median nerve post-intervention with neurodynamic test

    post-intervention

  • Neurophysiological test pre-intervention

    pre-intervention

  • Neurophysiological test post-intervention

    post-intervention

  • +2 more secondary outcomes

Study Arms (2)

Intervention Goup

EXPERIMENTAL

Actual Diacutaneous Fibrolysis

Other: Actual Diacutaneous Fibrolysis

Placebo Group

SHAM COMPARATOR

Sham Diacutaneous Fibrolysis

Other: Sham Diacutaneous Fibrolysis

Interventions

Diacutaneous Fibrolysis is a non invasive physiotherapeutic technique applied by means of a set of metallic hooks ending a spatula with bevelled edges that help to treat the muscles and conjunctive tissues and trying to improve mobility between mobility between muscle planes.

Intervention Goup

Sham Diacutaneous Fibrolysis is applied at a superficial level. A pinch of skin was held with the thumb of the palpatory hand and the tip of the spatula but without effect in the muscle because no penetrate in deep tissue

Placebo Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed medically with neurophysiological test of carpal tunnel syndrome (low and moderate intensity)

You may not qualify if:

  • Severe carpal tunnel syndrome
  • Previous surgery on the hand
  • hormonal factors: diabetes, thyroids pathologies, pregnant
  • cervical disfunctions
  • ulcerations or skins disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sandra Jiménez

Zaragoza, 50010, Spain

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Sand J, Graduated

    I

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 3, 2016

First Posted

March 3, 2016

Study Start

April 1, 2016

Primary Completion

September 1, 2016

Study Completion

October 10, 2016

Last Updated

November 21, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

The patient data were confidential and were assigned a number to each patient to maintain confidentiality

Locations